NCT03603977Recruiting
Simplified Treatment of Anti-retrovirus in China (C-STAR)
A Simplified Therapy Regimen Study of Lopinavir and Ritonavir Combined With Lamivudine for HIV-1 Infected Patients in the Real World of China
Source: ClinicalTrials.gov · Last updated 14 Sept 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To observe the efficacy and safety of simplified therapy regimen for treating with HIV-1 infected patients in Chinese real word.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 600 (estimated)
- First submitted
- 19 Jul 2018
- Start date
- 1 Nov 2017
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Guangzhou 8th People's Hospital
- Diseases
- HIV
- NCT number
- NCT03603977
What you commit to
- Study type: Observational
- Planned participants: 600
- From 1 Nov 2017 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Have participated in HIV vaccine clinical trial or other drug trials in the past three months.
- Patients who have the history of resistance or allergy to LPV/r or 3TC.
Other
- Patients who could not complete the scheduled follow-up (such as weakness and poor compliance).
Who the study is looking for
- HIV-1 infection confirmed
- Agree to use simplified therapy regimen.
- Agree to detect CD4 count at least once per half a year
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Guangzhou 8th People's Hospital Coordinator of this site? Confirm its status | Guangzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.